Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-04-08

Clinical Trial Update: Prednisone for Decompensated Congestive Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating prednisone for decompensated congestive heart failure has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: Hebei Medical University | Conditions: Heart Failure, Congestive | Phase 2, Phase 3 | Status: SUSPENDED